This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_AML_EXALLC for full statistics.
This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_AML_EXALLC for full statistics.
C3_AML
acute myeloid leukemia: Acute myeloid leukemia (AML) is a group of neoplasms arising from precursor cells committed to the myeloid cell-line differentiation. All of them are characterized by clonal expansion of myeloid blasts. AML manifests by fever, pallor, anemia, hemorrhages and recurrent infections.
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
429209 |
1. Apply sex-specific ruleNone |
429209 |
2. Check conditions
|
276 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
276 |
4. Check minimum number of eventsNone |
276 |
5. Include endpoints |
276 |
6. Filter based on genotype QC (FinnGen only) |
244 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
List of similar endpoints to Acute myeloid leukaemia based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
All | Female | Male | |
---|---|---|---|
Number of individuals | 244 | 94 | 150 |
Unadjusted period prevalence (%) | 0.07 | 0.04 | 0.08 |
Median age at first event (years) | 65.50 | 56.91 | 70.88 |
Not a core endpoint, no data to show.
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Index endpoint: C3_AML – Acute myeloid leukaemia
GWS hits: -
Loading Relationships table